Eiger BioPharmaceuticals

United States · 52 Employees
Eiger is a commercial-stage biopharmaceutical company focused on the development and commercialization of targeted therapies for serious diseases with an unmet need. All five Eiger rare disease programs have been granted FDA breakthrough therapy designation. Eiger's lead clinical programs are focused on the development of innovative therapies to treat and cure hepatitis delta virus (HDV) infection, the most serious and rapidly progressive form of viral hepatitis. Our HDV platform includes two first-in-class therapies in Phase 3 that target critical host processes involved in viral replication. Eiger's first FDA-approved therapy is Zokinvy for the treatment of Hutchinson-Gilford progeria syndrome and processing-deficient progeroid laminopathies - collectively known as progeria. In July 2022, the European Commission also granted Eiger marketing authorization for Zokinvy to treat progeria. For additional information about Eiger and its clinical programs, and for prescribing or safety information, please visit www.eigerbio.com. For our social media and community guidelines, including information on how to report adverse events, please visit www.eigerbio.com/social-media-guidelines/

概述

国家 United States
成立时间 2008
总部 2155 Park Blvd, Palo Alto, California 94306, US
电话号码 +1 650-279-9845
网站 http://www.eigerbio.com
LinkedIn http://www.linkedin.com/company/eiger-biopharmaceuticals-inc.
Twitter https://twitter.com/eigerbiopharma1
Facebook https://facebook.com/Eiger-BioPharmaceuticals-116014218895858/
员工数 52
行业 biotechnology,
简介 Eiger is a commercial-stage biopharmaceutical company focused on the development and commercialization of targeted therapies for serious diseases with an unmet need. All five Eiger rare disease programs have been granted FDA breakthrough therapy designation. Eiger's lead clinical programs are focused on the development of innovative therapies to treat and cure hepatitis delta virus (HDV) infection, the most serious and rapidly progressive form of viral hepatitis. Our HDV platform includes two first-in-class therapies in Phase 3 that target critical host processes involved in viral replication. Eiger's first FDA-approved therapy is Zokinvy for the treatment of Hutchinson-Gilford progeria syndrome and processing-deficient progeroid laminopathies - collectively known as progeria. In July 2022, the European Commission also granted Eiger marketing authorization for Zokinvy to treat progeria. For additional information about Eiger and its clinical programs, and for prescribing or safety information, please visit www.eigerbio.com. For our social media and community guidelines, including information on how to report adverse events, please visit www.eigerbio.com/social-media-guidelines/

技术

Adobe Marketing Cloud

Search Marketing

CloudFlare Hosting

Hosting

Cloudflare DNS

Domain Name Services

Google Tag Manager

Tag Management

Microsoft Office 365

Other

Mimecast

Email Providers

Mobile Friendly

Other

New Relic

Web Performance Monitoring

Outlook

Email Providers

WordPress.org

CMS

常见问题

Eiger BioPharmaceuticals 在哪里?

Eiger BioPharmaceuticals 的总部位于 2155 Park Blvd, Palo Alto, California 94306, US

Eiger BioPharmaceuticals 的电话号码是多少?

Eiger BioPharmaceuticals 的电话号码是 +1 650-279-9845

Eiger BioPharmaceuticals 的官方网站是什么?

Eiger BioPharmaceuticals 的公司官方网站是 http://www.eigerbio.com

Eiger BioPharmaceuticals 是做什么的?

Eiger BioPharmaceuticals 的业务有哪些?

biotechnology,life sciences

Eiger BioPharmaceuticals 的年收入是多少?

Eiger BioPharmaceuticals 的收入是 14929000美元

Eiger BioPharmaceuticals 有多少员工?

Eiger BioPharmaceuticals 有 52 名员工

Eiger BioPharmaceuticals 属于哪个行业?

Eiger BioPharmaceuticals 从事以下行业: biotechnology

Eiger BioPharmaceuticals 使用什么技术?

Eiger BioPharmaceuticals 使用的一些流行技术包括: Adobe Marketing Cloud,CloudFlare Hosting,Cloudflare DNS,Google Tag Manager,Microsoft Office 365,Mimecast,Mobile Friendly,New Relic,Outlook,WordPress.org

如何联系 Eiger BioPharmaceuticals?

Eiger BioPharmaceuticals 联系信息: 电话号码:+1 650-279-9845, 网站:http://www.eigerbio.com, 邮箱:mlu***@***.com

Eiger BioPharmaceuticals 的社交媒体链接是什么?

Eiger BioPharmaceuticals 领英:http://www.linkedin.com/company/eiger-biopharmaceuticals-inc.,fackbook:https://facebook.com/Eiger-BioPharmaceuticals-116014218895858/,twitte:https://twitter.com/eigerbiopharma1

Eiger BioPharmaceuticals 是一家上市公司吗?

是的,Eiger BioPharmaceuticals是一家上市公司,在nasdaq公开挂牌上市,上市交易代码:EIGR

Eiger BioPharmaceuticals 的最后一轮融资是什么时候?

暂无最近投资信息

谁投资 Eiger BioPharmaceuticals?

Eiger BioPharmaceuticals 有 0 家投资者,包括 。

管理层

Michael Lungrin

Sr. Director, Program Management & External Manufacturing

Chris M

Senior Manager, Purchasing

Bradford Lees

Senior Manager Finance Accounting

Amy Wall

Senior Director, Pharmacovigilance

Nicole Ramza

Sr. Director Clinical Operations

员工

Liz B

Clinical Operations Consultant

Kaci Schiermeyer

Project Coordinator Consultant

Diala Khouri

Medical Advisor / MSL Europe: Progeria and HDV

Ray

CMC Tech Ops

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google